SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Orchid Pharma informs about newspaper advertisement

08 Jun 2021 Evaluate
Orchid Pharma has informed that it enclosed the copies of newspaper advertisement published in the newspapers, i.e., Business Standard (English) and Makkal Kural (Tamil) for giving notice of the date and time of the Extraordinary General Meeting of the Company to be held on Tuesday, June 29, 2021 at 11:30 AM (IST) through Video Conference (VC)/ Other Audio Visual Means (OAVM), procedure for registering/ updating email addresses, Book Closure and e-voting details for the purpose of convening EGM of the Company. The same can be accessed on the website of the Company at www.orchidpharma.com. 

The above information is a part of company’s filings submitted to BSE.

Orchid Pharma Share Price

570.50 6.40 (1.13%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×